MARKET WIRE NEWS

Baird Small/Mid Cap Growth Equity Fund Q1 2025 Commentary

Source: SeekingAlpha

2025-05-28 09:30:00 ET

Summary

  • The first six weeks of the year continued the pattern in place for much of 2024, a rising stock market climbing on the back of a narrow group of companies which carried enough momentum to push equity indices to all-time highs.
  • The Baird Small/Mid Cap Growth portfolio decreased -10.6% in the first quarter, net of fees, compared to the -10.8% decline in our primary benchmark, the Russell 2500 Growth Index.
  • While slightly outperforming in a down market is nothing to brag about, we remain encouraged about our relative performance improvement as we outperformed the benchmark for the second quarter in a row.

Market Update

Read the full article on Seeking Alpha

For further details see:

Baird Small/Mid Cap Growth Equity Fund Q1 2025 Commentary
Repligen Corporation

NASDAQ: RGEN

RGEN Trading

-0.23% G/L:

$113.015 Last:

449,515 Volume:

$114.50 Open:

mwn-app Ad 300

RGEN Latest News

February 24, 2026 10:26:04 am
Repligen (RGEN) Q4 2025 Earnings Call Transcript

RGEN Stock Data

$8,061,398,164
55,615,260
0.31%
211
N/A
Biotechnology & Life Sciences
Healthcare
US
Waltham

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App